What does marketable securities unrealized gain loss mean?

Captures the change in the fair market value of the company's investment portfolio that has not yet been realized through a sale. This metric reflects the impact of market volatility on the company's non-operating assets and overall financial position.

Microbot Medical MBOT Marketable Securities Unrealized Gain Loss

Marketable Securities Unrealized Gain Loss at other companies

Healthcare Services GroupHCSG

$475K+480%

AbCellera Biologics Inc.ABCL

$200K0.0%

UMH

UMH PropertiesUMH

-$36.42M—

NVE CorporationNVEC

$9.13K-94.8%

Motorcar Parts of AmericaMPAA

$56.25K+132%

Gencor IndustriesGENC

-$509K-249%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesUnrealizedGainLoss.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's marketable securities unrealized gain loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's marketable securities unrealized gain loss?: Microbot Medical (MBOT) reported marketable securities unrealized gain loss of $222K in Q1 2026.
What does marketable securities unrealized gain loss mean?: Captures the change in the fair market value of the company's investment portfolio that has not yet been realized through a sale. This metric reflects the impact of market volatility on the company's non-operating assets and overall financial position.